Olympus Co. (OTCMKTS:OLYMY – Get Free Report)’s stock price fell 0.2% on Friday . The company traded as low as $13.16 and last traded at $13.16. Approximately 12,079 shares were traded during mid-day trading, a decline of 87% from the average session volume of 95,863 shares. The stock had previously closed at $13.18.
Analyst Upgrades and Downgrades
Separately, The Goldman Sachs Group downgraded Olympus from a “buy” rating to a “neutral” rating in a research note on Monday, June 15th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold”.
View Our Latest Stock Analysis on OLYMY
Olympus Price Performance
Olympus Company Profile
Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.
In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.
Further Reading
- Five stocks we like better than Olympus
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.
